Resources>Citations Database>A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement

A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement

Biointron 2023-12-21

Authors: Li Chen, Wenjing Qian, Fangfang Pan, Debin Li, Weiwei Yu, Li Tong, Yingying Yang, Qiming Xu, Jianfeng Ding. Ruixue Dai, Weiwei Xian, Xufeng Zhu, Pu Ren, and Huaxing Zhu

Journal: Immunotherapy

PubMed ID: 38126157

DOI: https://doi.org/10.2217/imt-2023-0256

Products & Services: BiTE-CD19xCD3 antibody was purchased from Biointron


Subscribe to our Citations Database
Recommended Articles
MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-145p in Patients Suffering from Gall Bladder Carcinoma
Nov 25, 2025
Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery

Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybri……

Aug 07, 2025
Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of ……

Aug 01, 2025
Inhibition of long-lived plasma cells, a critical role for Telitacicept treatment to systemic lupus erythematosus

Inhibition of long-lived plasma cells, a critical role for Telitacicept treatmen……

Jul 30, 2025

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.